irofulven has been researched along with acetylcysteine in 2 studies
| Studies (irofulven) | Trials (irofulven) | Recent Studies (post-2010) (irofulven) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
|---|---|---|---|---|---|
| 99 | 22 | 7 | 14,580 | 1,046 | 5,960 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Dokal, I; Hossain, U; Jackson, N; Kirwan, M; Plagnol, V; Pondarre, C; Tummala, H; Vulliamy, T; Walne, AJ | 1 |
2 other study(ies) available for irofulven and acetylcysteine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.
Topics: Acetylcysteine; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Damage; DNA Helicases; DNA Repair; Female; Gene Knockdown Techniques; HEK293 Cells; HeLa Cells; Hemoglobinuria, Paroxysmal; Histones; Humans; Male; Mitochondria; Mitomycin; Mutation; Pedigree; Phosphorylation; Reactive Oxygen Species; Sesquiterpenes | 2014 |